GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

Inicio・Lista de Acciones・BioArctic AB

B
BioArctic AB

Cerrado

319.6 1.91

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

319

Máximo

320

Métricas clave
By Trading Economics
Ingresos	-208M -29M
Ventas	-259M 133M
P/B Media del Sector	28.665 76.798
BPA	-0.98
Margen de beneficio	-21.576
Empleados	122
EBITDA	-206M -18M

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	2.8B 29B
Apertura anterior	317.69
Cierre anterior	319.6

BioArctic AB Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

19 dic 2025, 17:29 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19 dic 2025, 16:47 UTC

Principales Movimientos del Mercado

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19 dic 2025, 16:10 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

21 dic 2025, 23:51 UTC

Charlas de Mercado

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

21 dic 2025, 23:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 dic 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

21 dic 2025, 23:35 UTC

Charlas de Mercado

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

19 dic 2025, 22:33 UTC

Ganancias

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19 dic 2025, 22:19 UTC

Ganancias

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19 dic 2025, 21:48 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 21:44 UTC

Ganancias

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 21:38 UTC

Ganancias

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19 dic 2025, 21:00 UTC

Charlas de Mercado

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19 dic 2025, 20:23 UTC

Charlas de Mercado

Oil Futures End Down Week on Up Note -- Market Talk

19 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19 dic 2025, 18:38 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19 dic 2025, 18:00 UTC

Charlas de Mercado

Ganancias

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19 dic 2025, 17:41 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 17:24 UTC

Charlas de Mercado

Ganancias

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

19 dic 2025, 16:29 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19 dic 2025, 16:20 UTC

Adquisiciones, fusiones, absorciones

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19 dic 2025, 16:19 UTC

Adquisiciones, fusiones, absorciones

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19 dic 2025, 16:18 UTC

Adquisiciones, fusiones, absorciones

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19 dic 2025, 16:16 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 dic 2025, 16:16 UTC

Charlas de Mercado

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19 dic 2025, 16:05 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 16:04 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 15:37 UTC

Charlas de Mercado

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

Comparación entre iguales

Cambio de precio

BioArctic AB Esperado

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.